Silverfin false false 30/04/2025 30/04/2024 30/04/2025 A T Giusca 27/08/2024 Dr M Giusca 30/04/2024 R Giusca 30/04/2024 22 November 2025 medical 15696302 2025-04-30 15696302 bus:Director1 2025-04-30 15696302 bus:Director2 2025-04-30 15696302 bus:Director3 2025-04-30 15696302 core:CurrentFinancialInstruments 2025-04-30 15696302 core:ShareCapital 2025-04-30 15696302 core:RetainedEarningsAccumulatedLosses 2025-04-30 15696302 core:ComputerEquipment 2024-04-29 15696302 2024-04-29 15696302 core:ComputerEquipment 2025-04-30 15696302 2024-04-30 2025-04-30 15696302 bus:FilletedAccounts 2024-04-30 2025-04-30 15696302 bus:SmallEntities 2024-04-30 2025-04-30 15696302 bus:AuditExemptWithAccountantsReport 2024-04-30 2025-04-30 15696302 bus:PrivateLimitedCompanyLtd 2024-04-30 2025-04-30 15696302 bus:Director1 2024-04-30 2025-04-30 15696302 bus:Director2 2024-04-30 2025-04-30 15696302 bus:Director3 2024-04-30 2025-04-30 15696302 core:ComputerEquipment core:TopRangeValue 2024-04-30 2025-04-30 15696302 core:ComputerEquipment 2024-04-30 2025-04-30 15696302 core:CurrentFinancialInstruments 2024-04-30 2025-04-30 iso4217:GBP xbrli:pure

Company No: 15696302 (England and Wales)

MARMEDICA LTD

Unaudited Financial Statements
For the financial period from 30 April 2024 to 30 April 2025
Pages for filing with the registrar

MARMEDICA LTD

Unaudited Financial Statements

For the financial period from 30 April 2024 to 30 April 2025

Contents

MARMEDICA LTD

STATEMENT OF FINANCIAL POSITION

As at 30 April 2025
MARMEDICA LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 April 2025
Note 30.04.2025
£
Fixed assets
Tangible assets 3 966
966
Current assets
Debtors 4 2,854
Cash at bank and in hand 13,587
16,441
Creditors: amounts falling due within one year 5 ( 5,480)
Net current assets 10,961
Total assets less current liabilities 11,927
Net assets 11,927
Capital and reserves
Called-up share capital 100
Profit and loss account 11,827
Total shareholders' funds 11,927

For the financial period ending 30 April 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of MARMEDICA Ltd (registered number: 15696302) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Dr M Giusca
Director

22 November 2025

MARMEDICA LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 30 April 2024 to 30 April 2025
MARMEDICA LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 30 April 2024 to 30 April 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

MARMEDICA Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 11 Sweet Briar Close, Leavenheath, CO6 4NP, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The company's first accounting period is from incorporation on 30 April 2024 to 30 April 2025.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Income Statement as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

Period from
30.04.2024 to
30.04.2025
Number
Monthly average number of persons employed by the Company during the period, including directors 3

3. Tangible assets

Computer equipment Total
£ £
Cost
At 30 April 2024 0 0
Additions 1,199 1,199
At 30 April 2025 1,199 1,199
Accumulated depreciation
At 30 April 2024 0 0
Charge for the financial period 233 233
At 30 April 2025 233 233
Net book value
At 30 April 2025 966 966

4. Debtors

30.04.2025
£
Trade debtors 2,854

5. Creditors: amounts falling due within one year

30.04.2025
£
Amounts owed to directors 1,192
Accruals 1,440
Corporation tax 2,848
5,480

There are no amounts included above in respect of which any security has been given by the company.